Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

North American Vaccine

1989 FOUNDED
M&A STATUS
201-300 EMPLOYEES
M&A LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Provider of vaccination services intended to prevent infectious diseases. The company research, develop, and markets vaccines for the eradication of smallpox and the control of communicable diseases such as diphtheria, pertussis, polio, tetanus, pertussis, and other diseases, enabling children to immunize and fight against contagious diseases.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Other Industries
Drug Delivery
Other Devices and Supplies
Medical Supplies
Primary Office
  • 12103 Indian Creek Court
  • Beltsville, MD 20705
  • United States

North American Vaccine Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore North American Vaccine‘s full profile, request access.

Request full access to PitchBook

North American Vaccine Executive Team (1)

Name Title Board
Seat
Contact
Info
Sharon Mates Ph.D President